Walleye Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.85M Buy
87,500
+74,400
+568% +$6M 0.02% 652
2026
Q1
$1.14M Sell
13,100
-52,900
-80% -$5.07M ﹤0.01% 1959
2025
Q4
$6.34M Buy
66,000
+30,400
+85% +$2.95M 0.02% 972
2025
Q3
$3.39M Sell
35,600
-1,100
-3% -$101K 0.01% 1192
2025
Q2
$3.2M Sell
36,700
-64,100
-64% -$5.44M 0.01% 1159
2025
Q1
$9.06M Sell
100,800
-70,200
-41% -$6.28M 0.04% 480
2024
Q4
$13.7M Sell
171,000
-11,200
-6% -$970K 0.03% 470
2024
Q3
$16.4M Sell
182,200
-52,200
-22% -$4.39M 0.03% 426
2024
Q2
$18.4M Sell
234,400
-27,600
-11% -$2.26M 0.03% 398
2024
Q1
$22.8M Sell
262,000
-132,300
-34% -$11.3M 0.04% 357
2023
Q4
$32.5M Buy
394,300
+119,600
+44% +$9.12M 0.07% 185
2023
Q3
$21.5M Buy
274,700
+177,800
+183% +$14.9M 0.06% 239
2023
Q2
$8.54M Buy
96,900
+62,700
+183% +$5.4M 0.03% 459
2023
Q1
$2.76M Sell
34,200
-22,400
-40% -$1.83M 0.04% 548
2022
Q4
$4.4M Buy
56,600
+26,800
+90% +$2.17M 0.08% 301
2022
Q3
$2.41M Buy
+29,800
New +$2.68M 0.05% 459
2019
Q4
Sell
-3,300
Closed -$358K 2070
2019
Q3
$358K Buy
3,300
+1,700
+106% +$177K 0.02% 895
2019
Q2
$156K Hold
1,600
0.02% 1067
2019
Q1
$146K Buy
+1,600
New +$143K 0.02% 896

Other funds holding MDT

Walleye Capital's MDT Position: Q2 2026 in Review

Walleye Capital increased its Medtronic (MDT) stake by 9,895% in Q2 2026, buying an estimated $5.37M and bringing the position to 67,268 shares worth $5.26M. The position accounts for 0.02% of the portfolio, ranked #792.

Walleye Capital first reported a position in MDT in Q3 2018 and has held it in 13 quarters since. The position peaked at $45M in Q4 2025. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Walleye Capital held 67,268 shares of Medtronic worth $5.26M as of Q2 2026.
  • Walleye Capital bought 66,595 Medtronic shares in Q2 2026, an estimated $5.37M.
  • Medtronic made up 0.02% of Walleye Capital's portfolio in Q2 2026, its #792 holding.
  • Walleye Capital first reported a position in Medtronic in Q3 2018 and has held it in 13 quarters since.
  • Walleye Capital's Medtronic position peaked at $45M in Q4 2025.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.